My main concern is that it's here at this SP level, which means they weren't able to willing to wait for the results from any of the assays results they have coming.
Which means the pxrf readings were bad and wont increase the SP at all.
It would also imply that the feasibility study isn't expected to increase the share price at all either.
Which means we've got one new target for nickel/cobalt/copper in the tenement extension and the lithium left to check.
I could be wrong but that's the impression I'm getting.
AZS Price at posting:
22.5¢ Sentiment: Buy Disclosure: Held
